Photo taken from ESTRO/LinkedIn
Aug 11, 2024, 13:07
Targeting serine/glycine metabolism with sertraline can enhance radiotherapy responses in NSCLC – ESTRO
European Society for Radiotherapy and Oncology (ESTRO) shared on LinkedIn:
“Pre-clinical findings presented at ESTRO24 reveal that targeting serine/glycine metabolism with sertraline can enhance radiotherapy responses in NSCLC (non-small cell lung cancer). This approach radiosensitises the tumor and reduces immune suppression.”
Read further.
Source: ESTRO/LinkedIn
